Gene Editing By Spark Therapeutics Shows Promise

Gene Editing By Spark Therapeutics Shows Promise In Reversing Vision Loss By Amy Nordrum Spark Therapeutics announced positive results from a phase three trial to use gene editing to treat a form of inherited vision loss, Oct. 5, 2015. The company launched from the...
On